Delivery Order SPE2DB20D3101-SPE2DB24FRNU6
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.67, is a delivery order for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,115.28 firm fixed-price delivery order is for the supply of REYVOW 50 MG TABLET medication to the government. The contract has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,644.10 firm fixed-price delivery order is for the medical product REYVOW 100 MG TABLET UD 8S. The award has an ultimate completion date of December 12, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of August 16, 2024. The contract was awarded on August 15, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a ceiling value of $1,549.05 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, with a ceiling value of $1,467.90, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of June 9, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of pharmaceutical products, primarily the medication REYVOW 100 MG TABLET UD 8S, to the Defense Logistics Agency (DLA). The $2,452.62 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 9, 2022 with a completion date of March 10, 2022. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,452.62, is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of December 16, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REYVOW 50 MG TABLET UD 8S. The contract, valued at $2,641.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,452.04 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...